GenSight Biologics. (SIGHT.PA) Q3 2026 Earnings

Sep 29Confirmed
Q1 2025
Q3 2025
Q1 2026
Q3 2026
-0.05
-0.05
-0.05
-0.05

Details

Expected EPS
N/A
Actual EPS
-0.0503477151
Surprise EPS
N/A
Surprise Percent
N/A

Description

⁨GenSight Biologics.⁩ (⁦SIGHT.PA⁩) has reported earnings of ⁦-0.0503477151⁩ per share for ⁦Q3 2026⁩.

0 Comments

Share your thoughts